• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Thommen

Anonymous board for Thommen
Replies
47
Views
25K
anonymous
Replies
35
Views
19K
anonymous
Replies
4
Views
4K
Anonymous
Replies
2
Views
4K
Anonymous